Charles Schwab’s Core Scientific CORZ Stock Holding History

Charles Schwab’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.2M	Buy	3,249,565 +120,475	+4%	+$2.84M	0.01%	899
2026 Q1	$46.8M	Sell	3,129,090 -62,451	-2%	-$1.07M	0.01%	1206
2025 Q4	$46.5M	Buy	3,191,541 +162,842	+5%	+$2.84M	0.01%	1206
2025 Q3	$54.3M	Buy	3,028,699 +229,695	+8%	+$3.37M	0.01%	1115
2025 Q2	$47.8M	Buy	2,799,004 +399,044	+17%	+$3.99M	0.01%	1136
2025 Q1	$17.4M	Buy	2,399,960 +7,868	+0.3%	+$89.6K	﹤0.01%	1704
2024 Q4	$33.6M	Buy	2,392,092 +459,630	+24%	+$6.79M	0.01%	1400
2024 Q3	$22.9M	Buy	1,932,462 +590,946	+44%	+$6.12M	﹤0.01%	1624
2024 Q2	$12.5M	Buy	+1,341,516	New	+$6.85M	﹤0.01%	1930

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Charles Schwab's CORZ Position: Q2 2026 in Review

Charles Schwab increased its Core Scientific (CORZ) stake by 3.9% in Q2 2026, buying an estimated $2.84M and bringing the position to 3,249,565 shares worth $83.2M. The position accounts for 0.01% of the portfolio, ranked #899.

Charles Schwab first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Charles Schwab held 3,249,565 shares of Core Scientific worth $83.2M as of Q2 2026.
Charles Schwab bought 120,475 Core Scientific shares in Q2 2026, an estimated $2.84M.
Core Scientific made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #899 holding.
Charles Schwab first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.